4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000032
Options or other derivatives
- Chief Corp Dev & Strategy acquired 66,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Viswanadhan Krishnan · Chief Corp Dev & Strategy
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-01 | Grant or award : show line 1 in the form 10b5-1 Restricted stock units | +14,000 | 14,000 | D |
| 2026-03-01 | Grant or award : show line 2 in the form 10b5-1 Stock options (right to buy) | +52,000 | 52,000 | D |
Loading xslF345X05/wk-form4_1772572279.xml…